5-MeO-2,N,N-TMT: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Protected "5-MeO-2,N,N-TMT": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
Line 32: Line 32:


== References ==
== References ==
<references />
{{reflist|2}}


{{TiHKAL}}
{{TiHKAL}}

Latest revision as of 13:49, 4 September 2012

5-MeO-2,N,N-TMT
File:5-MeO-2,N,N-TMT.svg
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC14H20N2O
Molar mass232.321 g/mol
3D model (JSmol)

5-MeO-2,N,N-trimethyltryptamine (5-MeO-2,N,N-TMT) is a tryptamine derivative that is a hallucinogenic drug. It was invented by Alexander Shulgin and reported in his book TiHKAL (#45) [1]. It is claimed to show psychoactive effects at a dosage of 75-150mg orally, but these are relatively mild compared to other similar drugs, suggesting that while the 2-methyl group has blocked the binding of metabolic enzymes, it is also interfering with binding to the 5HT2A receptor target that mediates the hallucinogenic effects of these drugs.


References

  1. ↑ http://www.erowid.org/library/books_online/tihkal/tihkal45.shtml

Template:TiHKAL Template:Hallucinogenic tryptamines Template:Hallucinogen-stub

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=5-MeO-2,N,N-TMT&oldid=709208"